Nipent 10 mg Pulver zur Herstellung einer Injektionlösung/Infusionslösung
Active ingredient: Pentostatin
View notice details →
News topic
All current shortage notices related to Expected end: 2028-09, structured by product, country, active ingredient and reporting period.
7 noticesActive ingredient: Pentostatin
View notice details →Active ingredient: ERYTROPOETIN
View notice details →Active ingredient: RUPATADIN
View notice details →Active ingredient: Tranexamic Acid
View notice details →Active ingredient: Tranexamic Acid
View notice details →Active ingredient: MEMANTIN
View notice details →Active ingredient: MEMANTIN
View notice details →For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →